Impact of heparin‐aspirin therapy in patients with recurrent pregnancy loss characterized by thrombophilia resistant to low‐dose aspirin therapy: A retrospective study

Impact of heparin‐aspirin therapy in patients with recurrent pregnancy loss characterized by thrombophilia resistant to low‐dose aspirin therapy: A retrospective study

Abstract Purpose Heparin and aspirin (HA) therapy is used for antiphospholipid syndrome (APS)‐associated recurrent pregnancy loss (RPL). Low‐dose aspirin (LDA) is recommended for thrombophilic predispositions, such as antiphospholipid antibodies that do not completely meet the Sydney classification...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoko Ichikawa, Takami Watanabe, Yumene Kubota, Shigeru Matsuda, Daisuke Shigemi, Sayuri Kasano, Ryoko Yokote, Mirei Yonezawa, Nozomi Ouchi, Yasuyuki Negishi, Yoshimitsu Kuwabara, Toshiyuki Takeshita, Shunji Suzuki
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Reproductive Medicine and Biology
Subjects:
aspirin
heparin
lupus anticoagulant (LAC)
recurrent pregnancy loss
thrombophilia predispositions
Online Access:https://doi.org/10.1002/rmb2.12643
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/rmb2.12643

Similar Items